Locus Pharmaceuticals speeds discovery with IBM service

FRAMINGHAM (12/02/2003) - On Tuesday Locus Pharmaceuticals Inc. announced that it will accelerate its drug discovery efforts by supplementing its existing computing capacity by using IBM Corp.'s Deep Computing Capacity-on-Demand Center to provide additional supercomputing power.

Locus' current computing infrastructure delivers about 2.3 teraFLOPS (2.3 trillion floating point operations per second). This processing power is used in research and drug design to support the company's search for drugs to fight infectious diseases such as HIV and AIDS.

Locus will use the on-demand IBM service to speed its research efforts. "The flexibility, reliability, and availability of IBM's on-demand computing power will allow us to concentrate on the design of drug molecules, and in turn expand our drug discovery partner and client base," says Jeff Wiseman, Locus Pharmaceuticals' vice president of technology and informatics.

Other life science organizations that have recently turned to on-demand services to enhance their internal computing resources include Electro-Optical Sciences Inc. and the American Diabetes Association.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about IBM Australia

Show Comments